Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
112.19
-0.45 (-0.40%)
After Hours: 112.00 -0.19 (-0.17%)
May 23, 5:18PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 112.04 - 112.82
52 week 81.79 - 115.00
Open 112.77
Vol / Avg. 0.00/7.13M
Mkt cap 308.02B
P/E 20.45
Div/yield 0.80/2.85
EPS 5.49
Shares 2.75B
Beta 0.57
Inst. own 67%
Jul 12, 2016
Q2 2016 Johnson & Johnson Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 23, 2016
Johnson & Johnson at UBS Global Healthcare Conference
May 18, 2016
Johnson & Johnson Consumer and Medical Devices Business Review
May 5, 2016
Johnson & Johnson at Deutsche Bank Health Care Conference
Apr 28, 2016
Johnson & Johnson Annual Shareholders Meeting
Apr 22, 2016
Johnson & Johnson Annual Shareholders Meeting (Estimated)
Apr 19, 2016
Q1 2016 Johnson & Johnson Earnings Release
Apr 19, 2016
Q1 2016 Johnson & Johnson Earnings Call
Mar 17, 2016
Johnson & Johnson at Barclays Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '16) 2016
Net profit margin 24.55% 21.99%
Operating margin 30.28% 27.39%
EBITD margin - 35.56%
Return on average assets 12.77% 11.65%
Return on average equity 23.94% 21.87%
Employees 127,100 -
CDP Score - 99 B

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on over five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 58
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 57
Bio & Compensation  - Reuters
Paulus A. Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 54
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 57
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 53
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 63
Bio & Compensation  - Reuters
Mary C. Beckerle Ph.D. Director
Age: 61
Bio & Compensation  - Reuters
D. Scott Davis Director
Age: 64
Bio & Compensation  - Reuters
Mary Sue Sue Coleman Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters